Newly activated UI Cancer Center clinical trials

Newly activated UI Cancer Center clinical trials

The following studies have recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on Clinical Trials.gov. For more information or questions about a study, please email cancertrials@uic.edu or call 312-355-5112.

AFT-28: Direct oral anticoagulants (DOACs) versus LMWH +/- warfarin for VTE in cancer: A randomized effectiveness trial (CANVAS Trial). https://clinicaltrials.gov/ct2/show/NCT02744092?term=aft28&rank=1
Principal Investigator: Lawrence Feldman, MD
Research Sponsor: Alliance Foundation Trials, LLC

S0820: Double blind placebo controlled trial of eflornithine and sulindac to prevent recurrence of high risk adenomas and second primary colorectal cancers in patients with stage 0-III colon or rectal cancer, Phase III preventing adenomas of the colon with eflornithine and sulindac PACES
https://clinicaltrials.gov/ct2/show/NCT01349881?term=s0820&rank=1
Principal Investigator: Neeta Venepalli, MD
Research Sponsor: Southwest Oncology Group

Leave a reply

Your email address will not be published. Required fields are marked *